Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
308430
vs
K
KOSPI 200
Over the past 12 months, Cellbion Co Ltd has underperformed KOSPI 200, delivering a return of -18% compared to KOSPI 200's +116% growth.
Stocks Performance
308430 vs KOSPI 200
Performance Gap
308430 vs KOSPI 200
Performance By Year
308430 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cellbion Co Ltd
Glance View
Cellbion Co Ltd is a South Korean life-science company that makes and sells products based on cell and biomaterial technology. Its business sits close to the healthcare and aesthetic-care markets, where it supplies items used by clinics, hospitals, and other professional customers rather than everyday consumers. The company earns money by selling finished products and related materials, and it may also work with other businesses that need those products for their own brands or services. That means its revenue depends on product demand from medical and beauty channels, plus any business-to-business supply relationships it has built. What makes Cellbion different is that it plays a specialized role in a narrow part of the healthcare value chain. Instead of acting like a broad drug maker or mass-market retailer, it focuses on niche products where cell-based and biomaterial know-how matter, which can give it a more specialized customer base and a more technical sales process.